Endothelial glycocalyx in hepatopulmonary syndrome: An indispensable player mediating vascular changes.

Li, Liang; Cook, Christopher; Liu, Yale; Li, Jianzhong; Jiang, Jiantao; Li, Shaomin

Li, Liang; Cook, Christopher; Liu, Yale; Li, Jianzhong; Jiang, Jiantao; Li, Shaomin.

Afiliação

Li L; Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Cook C; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States.
Liu Y; Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li J; Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Jiang J; Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li S; Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Front Immunol ; 13: 1039618, 2022.

Article em En | MEDLINE | ID: mdl-36618396

Assuntos

Síndrome Hepatopulmonar; Humanos; Síndrome Hepatopulmonar/etiologia; Síndrome Hepatopulmonar/patologia; Glicocálix/patologia; Pulmão/patologia; Vasodilatação; Ligadura

Palavras-chave

angiogenesis; endothelial cell; endothelial glycocalyx; hepatopulmonary syndrome; intrapulmonary vascular dilatations; monocyte; nitric oxide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Hepatopulmonar Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google